Systasy Bioscience GmbH is a privately owned technology provider offering a proprietary breakthrough DNA barcoding technology for highly multiplexed transcriptomic analysis at the single cell level. This cutting-edge innovation enables Systasy to collaborate with partners in two major and rapidly expanding fields in the pharmaceutical and biotech industries.
Pathway Based Drug Discovery
Highly multiplexable pathway activity screens
Human Disease
Models
Deeply characterized patient-derived disease models
Viral Tropism
Profiling
Technology that powers your viral vector development for gene therapy
Single-Cell/Nucleus Transcriptomics
Dissect the complexity of heterogenous tissues at unparalleled resolution
We aim to gain deep insights into disease mechanisms and accelerate the development of effective treatments. With our pathway-focused approach, targets and drug candidates discovered from our platform address the truly relevant disease causes and display a markedly increased likelihood of being highly effectives.
Our Technology
Systasy’s technology is unique as it uses millions of molecular barcodes combined with human disease models to analyze hundreds of pathological processes simultaneously. It connects thousands of compound activities to an individual patient’s clinical and genomic data. Systasy’s technology lowers failure in subsequent clinical phases and leads to cost savings for our partners.
Collaboration is part of our DNA!
Ready to take your research to the next level? Contact us today to learn more about our services, pricing, and how we can help you achieve your scientific goals.
Ready to take your research to the next level? Contact us today to learn more about our services, pricing, and how we can help you achieve your scientific goals.